Kamama, Rosda .
HRN: 21-32-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/07/2022
05/14/2022
IVTT
500mg
Q8H
S/p LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes